Clinical trial
Comparison of Rabeprazole and Esomperazole for the Eradication of H. Pylori (CREATION Study)
NCT02767479 is registered in ClinicalTrials.gov with Hamamatsu University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Rabeprazole and Esomperazole for the Eradication of H. Pylori (CREATION Study)
- Lead sponsor
- Hamamatsu University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2012
- Completion date
- April 30, 2016
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
h. pylori infection